Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07207824Phase 3Not Yet Recruiting

DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT04934878Completed

Regional Treatment Flow and Prognosis ofTraumatic Thoracic Aortic Injuries：A Multi-center Retrospective Analysis in Zhejiang Province During 11 Years

Role: collaborator

All 3 trials loaded